Published in Endokrynol Pol on January 21, 2008
Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur J Endocrinol (2008) 1.04
Real-time ultrasound elastography - a new tool for diagnosing thyroid nodules. Endokrynol Pol (2010) 0.99
Phenotype and metabolic disorders in polycystic ovary syndrome. ISRN Endocrinol (2012) 0.95
Colorectal neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol (2013) 0.91
Acromegaly in a patient with normal pituitary gland and somatotropic adenoma located in the sphenoid sinus. Endokrynol Pol (2008) 0.88
Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL. J Clin Endocrinol Metab (2011) 0.85
[Management of thyroid diseases during pregnancy]. Endokrynol Pol (2011) 0.85
[Personality and behavioural disturbances, with delusional-hallucinatory and delirium episodes in the course of hyponatremia due to paraneoplastic inappropriate vasopressin secretion (SIADH)]. Psychiatr Pol (2007) 0.83
[Colloid cysts of the pituitary gland]. Neurol Neurochir Pol (2002) 0.81
Abnormalities in glucose homeostasis in acromegaly. Does the prevalence of glucose intolerance depend on the level of activity of the disease and the duration of the symptoms? Endokrynol Pol (2009) 0.80
The role of combined low-dose dexamethasone suppression test and desmopressin stimulation test in the diagnosis of persistent Cushing's disease. Case report. Endokrynol Pol (2010) 0.80
Late-onset hypogonadism among old and middle-aged males with prediabetes in Polish population. Aging Male (2015) 0.79
Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity. Ginekol Pol (2014) 0.79
Bilateral adrenal incidentaloma with subclinical hypercortisolemia: indications for surgery. Pol Arch Med Wewn (2014) 0.79
The high prevalence of testosterone deficiency in population of Polish men over 65 years with erectile dysfunctions. Aging Male (2012) 0.78
Transsphenoidal surgery for a life-threatening prolactinoma apoplexy during pregnancy. Neuro Endocrinol Lett (2012) 0.78
Fetal thyroid in two-dimensional ultrasonography: nomograms according to gestational age and biparietal diameter. Eur J Obstet Gynecol Reprod Biol (2012) 0.78
[Positive effects of DHEA therapy on insulin resistance and lipids in men with angiographically verified coronary heart disease--preliminary study]. Endokrynol Pol (2006) 0.77
The prevalence of prediabetes in population of Polish men with late-onset hypogonadism. Aging Male (2014) 0.77
[Testosterone deficiency in elderly men]. Pol Merkur Lekarski (2009) 0.77
Transsphenoidal surgery for Cushing's disease: the role of early post-operative serum cortisol measurements as a predictor of success--a prospective study. Endokrynol Pol (2013) 0.77
[Lowered ghrelin levels in acromegaly—normalization after treatment]. Endokrynol Pol (2006) 0.77
[Pathogenesis, evaluation and treatment of hypogonadism in men]. Endokrynol Pol (2009) 0.77
Acromegaly--a novel view of the patient. Polish proposals for diagnostic and therapeutic procedures in the light of recent reports. Endokrynol Pol (2014) 0.77
Proinsulin, adiponectin and hsCRP in reproductive age women with polycystic ovary syndrome (PCOS)--the effect of metformin treatment. Endokrynol Pol (2014) 0.77
[Phenotype of patients with gynecomastia]. Endokrynol Pol (2008) 0.77
The incidence of hypogonadotropic hypogonadism in type 2 diabetic men in Polish population. Biomed Res Int (2013) 0.76
[Surgical treatment of invasive pituitary adenomas (somatotropinoma or corticotropinoma)]. Neurol Neurochir Pol (2004) 0.76
Polish Society of Endocrinology Position statement on endocrine disrupting chemicals (EDCs). Endokrynol Pol (2015) 0.76
Ghrelin - growth hormone releasing and orexigenic hormone in men declines with age, insulin and with decrease in testosterone concentration. Neuro Endocrinol Lett (2008) 0.76
Bilateral, incidentally found adrenal tumours - results of observation of 1790 patients registered at a single endocrinological centre. Endokrynol Pol (2010) 0.75
Complications of Cushing's disease - prospective evaluation and clinical characteristics. Do they affect the efficacy of surgical treatment? Endokrynol Pol (2012) 0.75
Addison's Disease Revisited in Poland: Year 2008 versus Year 1990. Autoimmune Dis (2010) 0.75
Fetuin-A levels in lean and obese women with polycystic ovary syndrome. Endokrynol Pol (2014) 0.75
Gastroduodenal neuroendocrine neoplasms, including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol (2017) 0.75
Comparison of chromogranin A (CgA) levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males. Endokrynol Pol (2015) 0.75
Primary aldosteronism - recent progress and current concepts. Endokrynol Pol (2013) 0.75
[Gynecomasty as a first sign of adrenal carcinoma--case report]. Endokrynol Pol (2006) 0.75
[Consensus of the Polish Society of Endocrinology. Presurgical somatostatin analogs therapy in acromegaly]. Endokrynol Pol (2007) 0.75
Chromogranin A (CgA) in adrenal tumours. Endokrynol Pol (2013) 0.75
Increased size and vascularisation, plus decreased echogenicity, of foetal thyroid in two-dimensional ultrasonography caused by maternal Graves' disease. Endokrynol Pol (2014) 0.75
Adrenal tumour bigger than 5 cm - what could it be? An analysis of 139 cases. Endokrynol Pol (2017) 0.75
[Thyroidectomy as the last chance treatment for life threatening thyrotoxicosis. Case report]. Endokrynol Pol (2007) 0.75
The effects of testosterone replacement therapy in men with age-dependent hypogonadism on body composition, and serum levels of leptin, adiponectin and C-reactive protein. Endokrynol Pol (2020) 0.75
ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome. Neuro Endocrinol Lett (2005) 0.75
The relationship between efficacy of surgical treatment of Cushing disease and pathological -- immunohistochemical and ultrastructural -- confirmation of corticotroph tumour presence. Neurol Neurochir Pol (2012) 0.75
Iodine supplementation during pregnancy of hypothyroid women treated with L-thyroxine neither influences neonatal TSH nor prevents decrease in maternal free thyroid hormone concentrations in second and third trimesters. Endokrynol Pol (2016) 0.75
Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol (2017) 0.75
Consensus statement of the Polish Society for Endocrinology: presurgical somatostatin analogs therapy in acromegaly. Neuro Endocrinol Lett (2008) 0.75
[Transsphenoidal surgery of secretory and invasive pituitary adenomas (somatotropinoma or corticotropinoma)--own experiences]. Przegl Lek (2004) 0.75
Cinacalcet as symptomatic treatment of hypercalcaemia in primary hyperparathyroidism prior to surgery. Endokrynol Pol (2017) 0.75
Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol (2017) 0.75
[Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations]. Endokrynol Pol (2007) 0.75
Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society - state of knowledge as of December 2013. Prz Menopauzalny (2014) 0.75
Colorectal neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol (2017) 0.75
[The relationship between testosterone and dehydroepiandrosterone sulfate concentrations, insulin resistance and visceral obesity in elderly men]. Endokrynol Pol (2006) 0.75
Thyroid cancer diagnosed and treated surgically during pregnancy - a case report. Endokrynol Pol (2013) 0.75
[Macroprolactin in subjects with hyperprolactinaemia: clinical observations and relations between free PRL and PRL complexed with IgG]. Endokrynol Pol (2006) 0.75
[Gynecomastia--pathogenesis, diagnosis and treatment]. Endokrynol Pol (2005) 0.75
[Pathogenesis, diagnosis and treatment of osteoporosis in men]. Pol Merkur Lekarski (2008) 0.75
[Neuroendocrine tumors of the colon - management guidelines (recommended by The Polish Network of Neuroendocrine Tumors)]. Endokrynol Pol (2008) 0.75
Hyperthyroidism during pregnancy--the role of measuring maternal TSH receptor antibodies and foetal ultrasound monitoring. Endokrynol Pol (2014) 0.75
Neuroendocrine neoplasms of the small intestine and appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol (2017) 0.75
Body composition, glucose metabolism markers and serum androgens - association in women with polycystic ovary syndrome. Endokrynol Pol (2013) 0.75
[Thyrotropin--TSH secreting pituitary tumor]. Przegl Lek (2002) 0.75